Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business ...

Q3 2025 Total Net Product Sales of $12.5 Million, 79% Year Over Year Growth ~ ~ Q3 2025 Positive Cash Flow from Operations, Cash Position Grew to $22 Million ~ ~ Japan Clinical Trial (STS-J01) ...

Willamette football set for high-stakes quarterfinal showdown vs. Central Catholic

In the midst of the greatest season in program history, the Wolverines will face a powerhouse program with a trip to the 6A semifinals at stake.